Cynosure and Lutronic Announce Merger

Cynosure and Hahn & Company, which has recently acquired Lutronic, have entered into a definitive merger agreement for a strategic combination of Cynosure and Lutronic. Terms of the transaction have not been disclosed.

Both Cynosure and Lutronic are global providers of energy-based medical aesthetic treatment systems and related technologies. The merger aims to create a global leader in medical aesthetic systems with a diversified, innovative product portfolio and a commercial presence in over 130 countries.

The combined company will enable customers and patients to access a broader range of products and consumables. It will also provide a depth of related clinical training and services, expanded research and development capabilities, an enhanced geographic footprint to serve more customers around the world, and a reinforced supply chain to ensure seamless continuity of products and services.

“The strategic combination will create a combined company with the resources, product portfolio and expertise that will benefit our customers, partners and employees,” said Nadav Tomer, CEO of Cynosure. “We are thrilled that Cynosure is partnering with Lutronic as we believe this will create a distinct opportunity to combine two strong global players in energy-based medical device technology for aesthetics.”

“Partnering with Cynosure is a meaningful and transformational next step in diversifying our portfolio and scaling our company,” said Haelyung Hwang, Founder and CEO of Lutronic. “This strategic combination furthers Lutronic’s mission to drive innovation and provide superior products and customer service to aesthetics providers around the world. Cynosure’s innovative medical device technology, commercial infrastructure and best-in-class brand-building capabilities will broaden our product line and customer base globally.”

The transaction is expected to close in the first quarter of 2024, subject to customary closing conditions.